Tempest Therapeutics raises up to $7.5M in private placement
What's the deal? Tempest Therapeutics has announced a private placement of up to $7.5 million. The structure includes $2.5 million upfront, with up to roughly $5 million in additional gross proceeds if warrants are exercised in full.
Why the structure? The two-tranche approach ties the bulk of the funding to warrant exercises. That gives Tempest immediate capital now, while leaving the larger portion contingent on future investor decisions.
The signal: At $7.5 million, this is a modest raise — landing in the bottom quarter of comparable funding rounds by size. For small-cap biotechs, private placements like this offer a route to capital that doesn't depend on the timing or terms of a public market window.
Read more: aktiencheck.de
Image credit: Generated with Gemini
